Axokine: at a Glance
Although Axokine contains the ability to be a fresh weapon in the fight against fatness, the company has discarded pains to manufacture and promote the product. Most frequently regarded as a drug that fights obesity rather than a weight loss supplement, Axokine, an appetite suppressant that interrupts certain brain processes to give you the feeling that you are full, could be considered the health care industry’s answer to serious weight problems.Originally the drug was meant to be used as a treatment for ALS (Lou Gehrig’s Disease), but clinical testing revealed that it caused loss of appetite. Axokine’s manufacturer, Regeneron Pharmaceuticals, applied to do testing with overweight and diabetic subjects, but found that the drug was not overwhelmingly successful, so they discontinued it.
Axokine: Facts
It does not contain a certified product website nor is a comprehensive component record accessible. Regeneron had a variety of purposes for testing the drug, but it was unsuccessful in its attempts to pass its initial 3-year study, so it was never marketed as a either prescription or non-prescription diet aid. This appetite suppressant works by impeding certain brain processes, ultimately curbing the user’s hunger. Certified medical researches proved that Axokine was merely winning approximately 30 percent of the time, while remaining of the testers finished up rising antibodies to the synthetic chemical. In the weight reduction group, 30 percent can be measured victorious, however developers did not think this a winning assessment, so Axokine was not at all freed by the FDA as a recommended medicine.
Axokine: Positive Features
- Axokine has been extensively examined in major medical researches for FDA endorsement for security, efficiency and harmful effects.
- Axokine’s effectiveness is proven in numerous medical studies.
- Primary researches of Axokine did not disclose any important harm effects.
- Animal tests of Axokine did not illustrate the return weight increase following termination of the drug that is so frequent in diets and diet supports.
Axokine: Negative Features
- Axokine is not longer available because the manufacturer discontinued the FDA approval process due to mediocre success-rates in weight loss experiments.
- An extensively accounted huge level medical test reported unsatisfactory consequences for the fatness drug.
- Lasting harmful effects of Axokine, if it were there to utilize, might be severe.
Axokine: Conclusion
Axokine could have been the wonder tablet lots of overweight people are waiting for; however unfortunately it did not meet the stringent requirements drug companies must adhere to. Considered trivially efficient to productively market, Regeneron Pharmaceuticals pulled out their request for FDA endorsement. There are no strategies to revive the drug as of now, but that does not indicate that others will not follow it in the future.
